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ABSTRACT

Chronic obstructive pulmonary disease (COPD) is predicted to become the third
leading cause of death worldwide between 2020 and 2030. 1.2.3 Signs and symptoms of this
disease can be debilitating, however techniques can be taught to decrease impairments.
Suggested techniques for pulmonary recovery consist of supporting the upper extremities,
supporting the head and leaning forward. The purpose of the current study was to examine the
effects of recovery positions on the EMG activation of accessory muscles of respiration to
decipher which recovery position is the most ideal for COPD patients. Fourteen healthy adults
over the age of eighteen were recruited for this study. Bilateral EMG surface electrodes were
placed on the accessory muscles of breathing including upper trapezius, sternocleidomastoid,
pectoralis major (clavicular head), serratus anterior and latissimus dorsi. The subjects were
randomly assigned a series of four different experimental positions: control position with the
hands at the sides, standing with hands overhead, leaning forward with hands on knees and
sitting with forearms and hands supported by a table. In each position, EMG activity was
collected during three separate trials of maximal inspiration and maximal expiration. Results
indicated a significantly higher level of bilateral EMG activity in the upper trapezius and
serratus anterior in the hands on head position and of the latissimus dorsi during the hands on
knees position. In conclusion, standing with hands on head and standing with hands on knees
are two positions that are significantly advantageous for activating respiratory accessory
muscles and could be utilized by COPD patients during respiratory recovery.
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CHAPTER!
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is an umbrella term used to describe a
multitude of chronic lung diseases that impair lung airflow. 1 Lung diseases typically identified
under the term COPD are a leading cause of mortality and are predicted to become the third
leading cause of death worldwide between 2020 and 2030. 1,2.3 COPD has a prevalence
estimated at 4-10% worldwide and 37% in the United States. 4 , 5 Men, smokers and people
greater than 40 years of age have the highest prevalence of COPD which dramatically
increases above the age of75. 4, 5 Risk factors include cigarette smoking, decreased activity
and occupational exposures, such as organic and inorganic dusts, chemical agents and furnes. 4
Some causes can be from chronic abnormal inflammatory response oflung to noxious
particles or gases that result in small airway disease, such as obstructive bronchiolitis, and
parenchymal destruction, such as in emphysema. Symptoms include cough, sputum
production, wheezing, but most importantly dyspnea leading to decreased activity. Likely
contributing factors to dyspnea include pulmonary hypertension, secondary polycythemia,
systemic inflammation, and skeletal muscle dysfunction. It has also been documented that a
combination of these factors leads to diminished quality oflife, reduced exercise tolerance,
increased risk of cardiovascular morbidity, and greater risk of death? When dyspnea is
present, overall lung function can be evaluated with spirometry.
Spirometry testing for patients with COPD continues to gain clinical interest as an
important tool to assess disease severity, functional ability and lung capacities. Although
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spirometry can be utilized for many pulmonary diseases, when used for dyspnea the FEV 1 was
moderately correlated with patients' ratings of dyspnea (r=0.29; 95% CI, 0.22 to 0.35).6
Furthermore, spirometry has been used as an outcome measure of therapy, as well as for
prognostic purposes. It has been established that spirometry lung volurues, specifically vital
capacity, is reduced in most patients with COPD compared to healthy individuals. 7 The higher
the severity of the individual's COPD, the lower the spirometry values will be. Studies show
that physicians underutilize spirometry for diagnosis of COPD, which leads to
underestimation of disease severity and diagnosis. 8, 9 With proper training, it has been shown
that knowledge of spirometry use increases and helps physicians more properly diagnose
COPD. 10
Electromyography (EMG) is widely used as an important tool to assess muscular activity,
including the activity of respiratory accessory muscles, which are more often utilized with
people suffering from COPD. The reproducibility of the EMG technique was studied among
COPD patients and healthy subjects. It was concluded that this technique has acceptable
reproducibility in both groups of participants. It was also sensitive enough to detect different
breathing patterns when breathing against increasing inspiratory loads. ll Therefore, EMG has
bew proven to be a good tool to detect and assess the action potentials of respiratory
accessory muscular tissue.
In therapy, patients with COPD are often taught techniques to increase lung capacity,
clear airways, conserve energy and recover from strenuous activities. Suggested positions for
pulmonary recovery include supporting the upper extremities, supporting the head and leaning
forward. Patients should be encouraged to perform the position that helps their inspiratory
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muscles recover the fastest. It has been shown in patients with COPD that a forward leaning
trunk position has relieved dyspnea. 12 Along with the forward leaning postme and head and
neck in neutral alignment, it has been shown to reduce airway obstruction, which may
increase pulmonary function. 12 Forward leaning with arm support and forward leaning with
head and arm support induced increased activity of inspiratory accessory muscles dming
inspiration compared to neutral sitting positions for patients with COPDY However, there is
limited research that compares the different positions.
The forward leaning position also has been found to be associated with a significant
reduction in EMG activity of the scalene and sternocleidomastoid musciesY According to
research, when dyspnea and inspiratory efforts are increased, EMG activity ofthe scalene
muscles are also increased. 14 According to an article published in the Brazilian Journal of

Physical Therapy, there is an increase in sternocleidomastoid activity with unsupported arm
elevation while performing ADL's.1 5 Dming the use of unsupported arm elevation, two
factors become determinants of the altered respiratory pattern: lung hyperinflation and, to a
small degree, diaphragm reserve strength. Due to dynamic hyperinflation dming inspiration,
the respiratory muscles are placed in an unfavorable position on the length-tension curve,
reducing the strength generation capacity. IS During arm elevation at rest, there was a
significant decrease in vital capacity and a small decrease in functional residual capacity. 7
In addition to varying recovery positions, there are also a variety of inspiratory muscles

that assist in breathing. These skeletal muscles play an essential role in providing the
mechanical basis for respiration and movement. 3 The muscles utilized may include upper and
middle trapezius, latissimus dorsi, pectoralis major, erector spinae, internal and external
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obliques, intercostals, abdominals and serratus anterior. 2 Skeletal muscle dysfunction is
prevalent in all stages of COPD and significantly influences symptoms, functional capacity,
health-related quality of life, health resource usage and even mortality.3 Lomax et al.
compared the EMG activity of accessory inspiratory muscles of eight college swimmers after
front crawl sprints. It was concluded that inspiratory muscle fatigue affected the activity of
latissimus dorsi during the sprints. Another study looked at the effects of a physical therapy
program on accessory inspiratory muscle usage. After body posture realigrunent and
respiratory training, the EMG recordings indicated less effort of the accessory inspiratory
muscles. 16 There are numerous factors that can potentially affect inspiratory muscle activity,
but further research is needed to conclude which muscles assist the most and during what
phase of breathing.
The aim of the current study is to investigate the effects of recovery positions on the
EMG activation of accessory muscles of respiration and dynamic pulmonary function using a
hand held spirometer. The data from this study may be utilized to determine which recovery
positions may be the most effective for patients with COPD.

4

CHAPTER II
METHODS
This project was reviewed and approved by the University of North Dakota Institutional
Review Board (IRB-20l505-361) prior to initiation ofthe study (See Appendix).
Subjects
Subjects were recruited from a sample of convenience at the physical therapy
department at the University of North Dakota. The subjects participating in this study were
obtained on a voluntary basis and all subjects completed an informed consent form prior to
participation. (See Appendix) The selection criteria included healthy adults over the age of
18. The exclusion criteria included breathing difficulty with physical activity, injuries to the
chest or back in the past three months, and allergic reactions to adhesives. Each subject
completed a subject questionnaire and data collection form. The subjects attended one day of
testing in the Department of Physical Therapy on the University of North Dakota campus in
the School of Medicine and Health Sciences. The testing was completed in a private research
room for the confidentiality and privacy of the subjects. Subjects did not receive
compensation for participating in this study.
Instrumentation
Instnnnentation for this study included electromyography hardware and software. The
electromyography (EMG) data collection was performed using self-adhesive pre-gelled EMG
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surface electrodes over standard electrode sites of the following muscles: upper trapezius,
sternocleidomastoid, pectoralis major (clavicular

A

B

head), serratus anterior and latissimus dorsi. The
EMG data was collected using the Noraxon
MyoResearch XP software and the TeleMyo 2400
G2 telemetry system. Data analysis for the raw
EMG data was performed on a laptop computer
(Dell, Round Rock TX) using Noraxon
Figure 1.A&B. EMG Electrode placement ior
the accessory muscles of respiration used during
the study.

MyoResearchXP software (Noraxon, USA,
Scottsdale AZ).
Procedure
Prior to the initiation of the study, the EMG
equipment was set up and tested by the
researchers to ensure proper signal transmission
and reception. The subjects were tested
independently in the Department of Physical
Therapy located at the University of North
Dakota School of Medicine and Health
Sciences. The purpose and procedure for the
study were explained to the participants prior to
each participant signing a statement of informed

Figure 2. Pulmonary recovely positions

all head. £,. Hands on knees. and D. Seated with elbows on

table.
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consent, completing the intake survey, and initiation of data collection.
The collection ofEMG data required electrode site preparation, electrode placement,
connecting and testing the equipment. The electrode site preparation was perfonned in a
standardized fashion including removal of excess hair from the electrode site with an electric
razor, swiping the skin surface with 400 grit sandpaper, and wiping the area with an isopropyl
alcohol saturated towel. Electrode placement was detennined by using standard electrode
placement recommendations.(Criswe1l2011) Standard silver/silver chloride electrodes were
placed in a bipolar configuration at the appropriate sites using an inter-electrode distance of
approximately 1.5 cm. Skin impedance was assessed to be under 50 kOhm using the Noraxon
impedance analyzer (Noraxon, USA, Scottsdale AZ). The electrodes were connected to the
Telemyo 2400 G2 transmitter. (Figure lA&B) The EMG signals were transmitted to the
Telemyo 2400 G2 receiver and stored on a laptop computer (Dell Inc.). The raw EMG data
was later analyzed for intensity of activation of the muscles using the MyoResearch XP
software. (Noraxon USA, Inc. Scottsdale AZ)
Each subject perfonned mild muscle contractions to confinn appropriate electrode
placement and EMG equipment configuration. After the mild muscle contractions, the
subjects were instructed in perfonning maximal voluntary contractions (MVC) for the upper
trapezius, sternocleidomastoid, latissimus dorsi, and pectoralis major. The serratus anterior
MVC was detennined from the MVC position for the pectoralis major muscle.
The subjects were randomly assigned a series of four different experimental positions
including the control position with the hands at the sides, standing with hands overhead,
leaning forward with hands on knees and sitting with forearms and hands supported by a
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table. (See Figure 2 A-D) In each position, EMG activity was collected during three separate
trials of maximal inspiration and maximal expiration using a hand-held spirometer. (Jaeger
SpiroPro+@ SensorMedics Corp. Yorba Linda CA) The ventilatory volumes retained for
further analysis included the vital capacity of inspiration (VCin), forced expiratory volume in
one second (FEV 1), and forced vital capacity (FVC). During spirometry, the subjects utilized
a nose clip to minimize error. One of the researchers held the spirometer at a comfortable
position for the subject while the subject performed a slow, deep inspiration followed by a
forceful expiration and forceful inspiration. An average of three attempts in each position
were used for analysis. The spirometric measurements were followed by a trial of maximal
voluntary ventilation (MVV) for 10 seconds in the same position. The volume of air moved
during the MVV was not collected for analysis. Following the completion of data collection
in all experimental positions, the electrodes were removed from the subjects followed by
cleaning the areas with an isopropyl alcohol soaked towel.
Data Analysis
Raw EMG data was analyzed using the Noraxon Myoresearch Software Program. The EMG
data was normalized to the maximal voluntary contractions, rectified, and smoothed using the
root mean square (RMS) over 50 ms. collection frames. Composite data is presented as
average ± SD for all subjects within an experimental condition.

Statistical Analysis
Data are presented as mean±standard deviation. A one-way, repeated measures analysis of
variance was utilized to determine differences between the experimental trials for each
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individual muscle (alpha=O.05). The least significant difference post hoc test was utilized
when appropriate.
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CHAPTERUI
RESULTS
Fourteen subjects participated in the study including six females and eight males (see
Table 1). The data and analysis are combined for reporting purposes. The average age of the
subjects was 24±2. The average height of the subjects was 67.4±3.4 inches while the average
weight was 160±23 pounds.
Table 1. Sub.ied demographics.
N
Female
6
Male
8
14
Total

Age
23
25
24

Height (in)
64.2±1.8
69.9±1.7
67.4±3.4

Weight (Ibs.)
139±19
176±11
160±23

A one-way repeated measures ANOYA was calculated comparing bilateral EMG
activity of the upper trapezius, serratus anterior, and latissimus dorsi of 14 subjects in four
different positions: arms at sides, hands on head, hands on knees, and arms supported on table
(Figure 2A-D). A significantly higher level of bilateral EMG activity was observed in the
upper trapezius and serratus anterior in the hands on head position. A significantly elevated
level of bilateral EMG activity was observed in the latissimus dorsi muscle during the hands
on knees position. (See Table 2) At the same time, a one-way repeated measures ANOYA
was calculated comparing EMG activity of sternocleidomastoid and pectoralis major
bilaterally of the same 14 subjects in four different positions: arms at sides, hands on head,
hands on knees, and arms supported on table. No significant effect was found for the EMG
activity observed in the sternocleidomastoid and pectoralis major muscles. (See Table 2)
10

Table 2. Electromyographic (EMG) activity ofthe accessory muscles of ventilation during different pulmonary
recovery positions.
Hands on
Arms supported
Fvalue
Muscle
Hands at
Hands on
Head
on table
Side
Knees
(M±SD)
(M±SD)
(M±SD)
(M±SD)
19.8±12.4
S.2±S.4
FC3,14)-20.678, p<O.OOI,
6.0±7.9
9.0±8.2
R Upper Trap
n~.614, poweF1.0
22.0±16.2
6.2±5.0
5.8±3.8
10.0±7.4
FC3, 14)-12. 773, F.003,
L Upper Trap
n~.496, poweF.91
23.6±13.4
26.0±17.2
21.1±l5.9
23.4±13,3
NSD, poweF.584
RSCM
NSD, poweF.209
21.9±11.6
LSCM
23.6±13.8
23.9±l6.2
24.9±12.S
6'!±4.5
13.4±12.4
RPecMajor
6.7±S.9
8.1±6.1
NSD, poweF.497
NSD, poweF.213
12.0±8.0
7.3±S.8
13.9±lO.0
13.6±l6.7
LPec Maior
22.7±12.0
IS.0±13.4
R Serratus Ant 10.1±63
7.7±5.4
FC3,14) 11.509, p O.OOS,
n~.470, poweF.880
34.7±32.6
17.4±16.3
L Serratus Ant
143±11.6
11.8±10.8
FC3,14)-7.926, p-0.015,
n~379, poweF.740
12.9±8.5
10.5±6.6
223±11.6
14.9±11.6
RLat
FC3, 14)-7.898, p-O.01S,
n~.378, poweF.738
11.2±7.5
13.4±8.7
21.6±9.9
14.7±11.6
F(3,14) 9.733, p<.OOI,
LLat
"0=.428, poweF.995

A one-way repeated measures ANOVA was calculated companng VCm, FVC, and
FEV 1 average values of 14 subjects in four different positions: anns at sides, hands on head,
hands on knees, and arms supported on table. No significant effect was observed for the
pulmonary ventilation values. (See Table 3).
Table 3. Pulmonar volumes observed during spirometry in four different pulmonary recovery positions.
Pulmonary
Hands on Knees
Arms supported
Hands at Side
Hands on Bead
F value
Measure
(M±SD)
(M±SD)
(M±SD)
on table
(M±SD)
4.5±.9
4.6±l.l
4.5±1.0
VCin
4.5±0.9
NSD,
poweF.!75
4.7±1.0
FVC
4.6±O.9
4.6±0.9
4.7±l.l
NSD,
poweF.141
4.0±0.8
4.0±0.6
NSD,
FEV!
4.0±0.7
4.1±0.7
poweF.564
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CHAPTER IV
DISCUSSION
This study aimed to find the effects of respiratory recovery positions on the EMG
activity of accessory muscles of respiration and pulmonary function using a handheld
spirometer. The sample subjects tested were healthy, young adults. Data was applied and
related to COPD to determine which recovery positions may be the most effective for dyspnea
associated with reduced pulmonary ventilation.
No significant effect was found comparing EMG activity of the sternocleidomastoid
and pectoralis major in each of the four positions. Also, no significant effect was found when
comparing the four different positions and their respective spirometry values. This is
consistent with previous studies that also examined maximal inspiratory and expiratory
pressures with a spirometer. Bhatt et al. researched spirometry, maximal inspiratory and
expiratory measures, and diaphragmatic excursion during tidal and vital capacity. The specific
positions tested were sitting, supine, and tripod, which consisted of sitting forward with hands
supported on the knees. Although the tripod position is not identical to any of the four
positions in the current study, it is similar to a combination of sitting with elbows supported
and standing with hands on knees. It was found that there is no difference in the tripod
position compared to sitting and supine positions measuring spirometry, maximal inspiratory
and expiratory pressures and diaphragmatic excursion. 17 Therefore, the results of the current
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study parallel previous research in concluding that there are no pulmonary differences in
recovery positions compared to a control position.
Although the different recovery positions do not provide a significant difference in
lung volumes, the positions have shown changes in how respiratory muscles are utilized. The
results of the current study concluded that there was a significantly higher level of bilateral
EMG activity of the upper trapezius and serratus anterior while participants were in the hands
on head position. There was also a significantly higher level of bilateral EMG activity in the
latissimus dorsi muscle during the hands on knees position. This coincides with past studies
that have looked at respiratory muscles and COPD.
O'Donnell et al. reviewed the abnormalities of pulmonary gas exchange, respiratory
mechanics, and compensatory adaptations of the respiratory system that develop in response
to increasing physiological impairment, such as with mild COPD. It was concluded that
patients with mild COPD had an increased contractile respiratory muscle effort. IS This was
discussed as being a mechanism to maintain effective alveolar ventilation to compensate for
pulmonary gas exchange abnormalities. Therefore, if COPD causes an increased respiratory
muscle effort, it would be essential to understand what body positions could assist with
respiratory muscle contraction. Creating an advantageous position for the accessory
respiratory muscles would allow for better energy conservation and more efficient breathing
after an increase in activity level. The current study produced results that indicate standing
with hands on head and standing with hands on knees are two positions that have significantly
activated respiratory accessory muscles. IS
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Besides increasing accessory muscle contractile force and putting the lungs in a more
favorable position, the respiratory recovery positions used by many patients with COPD may
have another purpose. Gosselink et al. looked at a rehabilitation program for COPD that
consisted of breathing techniques, pursed lips breathing, forward leaning, active expiration,
and inspiratory muscle training. Focus was put on the forward leaning posture and its
potential to relieve dyspnea. It was discovered that the forward leaning posture had less to do
with accessory respiratory muscles and more to do with the abdominal musculature. 19
Contracted abdominals increased pressure in the abdominal cavity, which supported the
diaphragm, causing a reduction in dyspnea. The forward leaning posture also showed
decreased EMG activity of the scalene and sternocleidomastoid. Therefore, the forward
leaning position decreased dyspnea by providing a stronger abdominal contraction that
increased the support for the diaphragm while decreasing accessory muscle recruitment. 19
Gerling et al. looked at the capability of the latissimus dorsi to generate force. The article
found that the latissimus dorsi has the largest cross sectional area as a muscle, but lack of
sarcomere distribution parallel to the muscle provides it with only moderate force
production. 2o Despite this, the large cross sectional area can provide accessory breathing
capabilities with the arms extended and, with its attachment to the trunlc, moderate expansion
of the chest for breathing. In the current study, this was shown with the EMG results in the
hands on knees position, as the latissimus dorsi had increased EMG activity while the upper
extremities were extended in weight bearing, which allowed chest movement.
The results of the current study are consistent with past research, indicating that
respiratory recovery positions do not change lung volumes and have minimal effect on
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contractility of respiratory accessory muscles. The results of this study were restricted to only
healthy individuals. Therefore, to acquire data that is more applicable to COPD patients,
future studies should include participants who have COPD or a pulmonary disorder. Also, the
current study focused on accessory muscle recovery positions, but did not require that the
participants perform any physical activity upon data collection. Further research should be
performed to see if the respiratory accessory muscle activity increases in the desired positions
secondary to exercise and is applicable to athletes, as to which positions help them recover
more effectively. This study looked at the EMG of the muscles for 10 seconds of heavy
breathing and only 1 maj or breath for lung volumes. Minute ventilation for lung volumes in
the positions and EMG findings for potential fatigue could also provide insight into this topic
with future research. It would also be beneficial to investigate the role of abdominal
musculature in respiratory recovery. If future research is conclusive with Gosselink et al.'s
findings, adding abdominal strengthening to COPD therapy interventions would be highly
beneficial.
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CHAPTER V
CONCLUSION
The evidence from this study shows that there is an increase in EMG activity for bilateral
sternocleidomastoid and upper trapezius muscles in the hands on head position, producing
significant differences compared to the control position of standing with arms resting to the
side. There also was a significant difference in values for EMG activity in the latissimus dorsi
muscle in the position of leaning forward with hands on the knees. Despite the increase in
muscle activity in these positions, pulmonary function measured using spirometry did not
produce any significant values in all measurements taken. These positions may provide relief
and allow for better accessory respiratory muscle activation and use as a recovery position for
COPD patients despite the results not producing significant recovery in healthy participants.
The two positions with increased EMG activity should be demonstrated to clients with COPD
as a recovery position option during situations of shortness of breath.
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Please provide the information requested below. Handwritten forms are not accepted - responses must be typed on the form.
Principal Investigator: ::.D.ca.cVl_·d_R_e_l_lin...,g"',_P_T",,,P=h.:::.Dc.c._ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Telephone:

777-4091

E-mail Address: david.relling@med.und.edu

Complete Mailing Address: Dept ofPT RID 1510, 501 N Columbia Rd Stop 9037, Grand Forks ND 58202-9037
School/College: Medicine and Health Sciences

Department: Physical Therapy

Student Advisor (if applicable):
Telephone:

E-mail Address:

---------------------Address or Box #:
-----------------------------------------------------------School/College: ____________________________ Department:

*** All IRB applications must include a Kev Personnel Listing.
Project Title: EMG activity of Accessory Muscles of Breathing during Recovery Positions

Proposed Project Dates: Beginning Date:

May 26, 2015

Completion Date:

May 1,2016
----;(I;-n-clc'u...;dl"'·n'-g":;d'-at=a'-'an:":a"ly-s7is7) -

Fnnding agencies supporting this research: N/A

------------------------------------Did the contract with the funding entity go through UND Grants and Contracts Administration?
0 YES or 0 NO
Attach a copy of the contract. Do not include any budgetary information. The IRE will not be able to review the study without a
copy of the contract with the funding agency.

Does any researcher associated with this project have an economic interest in the research, or act as an

o
---------=o

o

YES or ~ NO

officer or a director of any outside entity whose financial interests would reasonably appear to be
affected by the research? If yes, submit on a separate piece of paper an additional explanation of the
fmaneial interest. The Principal Investigator and any researcher associated with this project should
have a Financial Interests Disclosure Document on me with their department.

Will any research participants be obtained ]i'om another organization outside the University of North
YES or ~ NO Dakota (e.g., hospitals, schools, public agencies, American Indian hibes/reservations)?

-------------

Will any data be collected at or obtained from another organization outside the University of North
YES or ~ NO Dakota?

If yes to either of the previous t\vo
questions, list all organizations:

Letters from each organization must accompany this proposal. Each letter must mustrate tilat the organization
understands its involvement and agrees to participate in the study. Letters must include the name and title of the
individual signing the letter and should be printed on organizational letterhead.
Does any external site where the research will be conducted have its own IRE?

D YES D

If yes, does the external site plan to rely on UND's IRB for approval of this study?
(If yes, contact the UND IRE at 701 777-4279 for additional requirements)

NO

D YES D

I:2J
NO

N/A

I:2J

N/A

If your project has been or wi1I be submitted to other IREs, list those Boards below, along with the status of each proposal.
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Date submitted:

Status:

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Date submitted:

Status:

D
D

Approved
Approved

D
D

Pending
Pending

(include the name and address of the IRE, contact person at the IRB, and a phone number for that person)
Type ofl'roject: Check "Yes" or "No" for each of the following.

I:2J
D

YES or
YES or

D
I:2J

NO
NO

New Project
Continuation/Renewal

D
I:2J

YES or
YES or

I:2J
D

NO

Dissertation/Thesis/Independent Study

NO

Student Research Project

D

YES or

I:2J

NO

D
D

YES or

I:2J
I:2J

NO

Is this a Protocol Change for previously approved project? If yes, submit a signed Protocol Change Form,
along with a signed copy ofthis form with the changes bolded or highlighted.
Does your project involve abstracting medical record information? If yes, complete the HlPAA
Compliance Application and submit it with this form.

NO

Does your project include Genetic Research?

YES or

Subject Classification: This study will involve subjects who are in the following special populations: Check all that apply.

D
D
D

Children « 18 years)
Prisoners

I:2J

UND Students

o

Pregnant WomenlFetuses

Cognitively impaired persons or persons unable to consent

D Other
Please use appr-'-o-'-pr""i"'at-'-e-c"'he~c:;-k:CCli:::st~w=he~n:-cc;h:-Oi"'ldr;::e~n:-,-::p-'-ri:::so~n~e-'-r~s,-p-'-r~egn:--::an--:-tw-o-m-::e-::n,-o~r:-p:-e:-o-::p"'le-'-w=ho"""ar:-e-un-a"'b;-le-:t-o-c-o-ns-e-n"Ct-w""'il""l"'"b-e-involved in the research.
This study will involve: Check all that apply.

D

Deception (Attach Waiver or Alteration of informed

D
D
D
D
I:2J

Radiation

Consent Requirements)
New Drugs (IND) IND # _ _ _,Attach Approval
Investigational Device Exemption (IDE) # _ _~Attach Approval
Non-approved Use ofDrug(s)

D
D
D
D
D

Stem Cells
Discarded Tissue
Fetal Tissue
Human Blood or Fluids
Other

None of the above will be involved in this study

I. Project Overview
Please provide a brief explanation (limit to 200 words or less) ofthe rationale and purpose of the slndy, introduction of any
sponsor(s) of the study, and justification for nse of human subjects and/or special popnlations (e.g., vnlnerable populations such
as children, prisoners, pregnant women/fetuses),

During physical activity, individuals with pulmonary disease experience shor-mess of breath, fatigue, and
limited function. Fear of shOliness of breath spirals into sedentary behavior and declining physical
nmction. Recovery positions, such as leaning forward while suppoliing foreanns onto a table, have been
proposed to augment breathing control and reduce shOliness of breath. It has been postulated that increased
activity of muscles on the trunk, called accessory muscles of breathing, is a key component of breath
recovery. The pUl1Jose of tlus study is to assess accessory muscle activity using electromyography (EMG)
and size of breath volume in different recovery positions.

Please provide a thorough description of the procedures to be used by addressing the instructions under each ofthe following

categories.
1. Subject Selection.
a) Describe recruitment procedures (i.e., how subjects will be recruited, who will recruit them, where and when they will be
recruited and for how long) and include copies of any advertisements, fliers, etc., that will be used to recruit subjects.

Subjects will be recruited from the UND professional physical therapy classes. A flier (see attached)
will be displayed in the department dnring the summer 2015 and fall 2015 semesters. The principle
investigator will annonnce the posting of the flier to stndents enrolled in the professional program.
b) Describe your subject selection procedures and criteria, paying special attention to the rationale for including subjects
from any of the categories listed in the "Subject Classification" section above.

Subjects must be apparently healthy, 18 years of age, free of pulmonary disease, and no recent
injuries or conditions affecting the ability to breath or assume the experimental positions. The use of
UND stndents in the professional physical therapy program reflects a sample of convenience.
c) Describe your exclusionary criteria and provide a rationale for excluding subject categories.

Under the age of 18 due to the inability to provide their own consent (minor). Subjects with
pulmonary disease or recent injnries or conditions affecting the ability to breath or assume
experimental positions are excluded because the study is expected to challenge the pulmonary system
during assessment of the volume of breathing with a spirometer. Additionally, injuries or conditions
affecting the ability to breath or assume the testing positions could produce undue discomfort for the
subject. The EMG electrodes utilize a tape-like adhesive for adherence to the skin and therefore
individuals with tape allergies will be excluded. Therefore, apparently healthy individuals over the
age of 18 will be utilized for the stndy.
d) Describe the estimated number of subjects that will participate and the rationale for usil)gthat number of subjects.

It is estimated that 30 subjects will be recruited into the study. Each subject will serve as their own
control in the different breathing recovery positions. The 30 subjects are expected to provide a
normative distribution ofEMG and pulmonary function testing for healthy individuals. At the same
time, this number of subjects should provide the statistical power needed to identify significant
differences in EMG activity or lnng volumes due to the different recovery positions.
e) Specify the potential for valid results. If you have used a power analysis to determine the number of subjects, describe
your method.

A statistical power analysis was not performed. However, in previous studies with EMG we have
observed 20-30 subjects provides adequate data to determine effectiveness of position or movement
changes on the muscles being studied.
2. Description of Methodology.
a) Describe the procedures used to obtain informed consent.

The principle investigator will annonnce the availability of the study to students in the professional
program. A flyer will be used to provide additional information. Potential participants will be
provided with an overview of the purpose, study design, risks and results/outcomes of the study.
Each subject will be infOlmed of the potential for adverse effects. Subjects will be provided with the
written consent form. Time will be allowed for any potential questions or concerns. Piror to the
initiation of subject participation, each subject must provide verbal and ,witten consent (see consent
form)
b) Describe where the research will be conducted. Docmnent the resources and facilities to be used to cany out the proposed
research. Please note staffmg, funding, and space available to conduct this research.

The research will be conducted in the Department of Physical Therapy in the School oflVledicine &
Health Sciences at the University ofNOlth Dakota. The dep31iment Ims both electromyography
(ElvfG) software and hardware 8-vailable for this project. The Noraxon Telemyo 2400 unit for EMG
data collection and analysis is available within the department. In addition, the department has a
SpiroPro (SensorMedics Corp, Yorba Linda CA) spirometer to obtain breathing volumes. The

principle investigator has experience in utilizing both pieces of equipment and software. The UND
PT department will provide the EMG electrodes and spirometer mouthpieces as needed.
c) Indicate who will carry out the research procedures.

The principle investigator, Dr. David Reiling, will perform subject consent and oversee all aspects of
the research project. Students in the professional physical therapy program (Joel Kramer, Kelsey
Meyer, Eric Nefstead, and Daniel Vilaubi) will assist with subject recruitment, intervention (data
collection) and data analysis. Dr. ReIling has training and experience using both the EMG system and
SpiroPro spirometer. Joel ICramer, Kelsey Meyer, Eric Nefstead, and Daniel Vilaubi have undergone
training on the EMG system and will obtain proficiency with the SpiroPro spirometer prior to
initiation of the study.
d) Briefly describe the procedures aud techniques to be used and the amount oftime that is required by the subjects to
complete them.

Subjects will initially be fit with pre-gelled, self-adhesive surface electrodes placed over the motor
points of the relevant muscles. The electrodes collect underlying electrical activity within the
subject's muscles but do not provide any electrical shock or current to the subject. The muscles to be
monitored include upper trapezius, sternocleidomastoid, latissimus dorsi, pectoralis major, and
serratus anterior (See attached diagram). The subjects will be asked to wear tank tops to facilitate
access to the muscles and protect modesty. Prior to electrode placement, the skin will be prepared in
a standardized fashion and skin impedance will be measured to ensure adequate electrical conduction
at each site. Preparation of the skin includes removing excess hair from the electrode site with an
electric clipper and wiping the skin surface lightly with 400 grit sandpaper followed by wiping the
area with isopropyl alcohol wipes. The electrodes will be connected to a transmitter which will be
placed in a belt around the subject's waist. The EMG signals will be transmitted to a receiver and
then to a computer. Raw EMG data will be obtained for analysis. Breathing volumes will be
assessed using the SpiroPro spirometer. Nose clips will be placed on the subjects nose to assure
accurate breathing volume through the spirometer. Subjects will place the spirometer mouthpiece
into the mouth and breath deeply for 15 seconds. The volume in 15 seconds will be used to calculate
maximal minute volume. Each subject will perform one session of deep breathing at each of the body
positions used for the study (relaxed standing, standing with hands clasped overhead, standing with
hands on knees, and sitting with arms supported on a table). The EMG activity will be collected
while the subject is performing the deep breathing to determine the activity in the accessory muscles
of breathing. The four experimental body positions will be assigned randomly with 2 minutes of rest
provided between each session of deep breathing.
e) Describe audio/visual procedures aud proper disposal of tapes.

No audio or visual data will be collected during the study.
f) Describe the qualifications of the individuals conducting all procedures used in the study.

David Relling is a faculty member in the department of physical therapy. He has performed research
projects with EMG and spirometers in the past. All key personnel have received training on the EMG
equipment. All key personnel have completed IRE training.
g) Describe compensation procedures (payment or class credit for the subjects, etc.).

No compensation will be provided for subjects participating in the study.
Attachments Necessary: Copies of all instruments (such as survey/interview questions, data collection forms completed by
subjects, etc.) must be attached to this proposal.
3. Risk IdeIlltH:1catkm.

a) Clearly describe the anticipated risks to the subject/others including any physical, emotional, and financial risks that might
result limn this study.

The potential physical risks associated with this study are minimal. The EMG electrode placement
and analysis is a non-invasive procednre utilized in clinical practice. Minor skin inilation from the
skin preparation and EMG electrodes is possible. The use of a spirometer and assessing breathing

volumes with minute ventilation may lead to dryness and irritation of the mouth. Water will be
available for subjects during the study.
b) Indicate whether there will be a way to link subject responses andlor data sheets to consent forms, and if so, what the
justification is for having that link.

Subject's names will not be used in any reports of the results of this study. Each participant will
complete a written consent form. There will be no association between the written consent form and
the subjects data. At the completion of the study, the research data and the consent forms will be
stored in separate, locked locations in the Department of Physical Therapy for 3 years at which point
the forms and data will be destroyed. Data will only be reported in aggregate form to protect the
confidentiality of all subj ects.
c) Provide a description of the data monitoring plan for all research that involves greater than minimal risk.

N/A
d) If the PI will be the lead-investigator for a multi-center study, or if the PI's organization will be the lead site in a multicenter study, include information about the management of information obtained in multi-site research that might be
relevant to the protection of research participants, such as unanticipated problems involving risks to participants or others,
interim results, or protocol modifications.

N/A
4. Subject Protection.
a) Describe precautions you will take to minimize potential risks to the subjects (e.g., sterile conditions, informing subjects
that some individuals may have strong emotional reactions to the procedures, debriefmg, etc.).

Each subject will be provided with their own spirometer mouthpiece. New, clean disposable
electrodes will be utilized for each subject. The possibility of skin irritation will be minimized by
proper skin preparation and subject screening prior to participation. Subjects will be informed of the
placement of electrodes to prevent emotional reactions to concerns about impeding on the subjects
personal space. Investigators will use appropriate draping of the subject during preparation and
placement ofEMG electrodes. The investigator(s) or participant may stop the experiment at any time
if the participant is experiencing discomfort, pain, fatigue, or any other symptoms that may be
detrimental to their health. All subjects will be allowed to terminate their participation in this study at
any time without prejudice.
b) Describe procedures you will implement to protect confidentiality and privacy of participants (such as coding subject data,
removing identirying information, reporting data in aggregate form, not violating a participants space, not intruding where
one is not welcome or trusted, not observing or recording what people expect not to be public, etc.). If p8.1iicipants who are
likely to be vulnerable to coercion and undue influence are to be included in the research, define provisions to protect the
privacy and interests of these participants and additional safeguards implemented to protect the rights and welfare of these
pmicipants.

Subject data will not be linked to the consent form in order to protect the confidentiality ofthe subjects.
Data collection forms and electronic data collection EMG files will be linked together using an alphanumeric code. Data will only be reported in aggregate form to assure privacy of the subjects.
P81'ticipants will wear appropriate clothing to allow access to the EMG electrode sites. However,
researchers will utilize appropriate draping with sheets and towels during placement of the electrodes
to assure patient comfolt and modesty.
c)

Indicate that the subject will be provided with a copy ofthe callsent form and how this will be done.

Prior to participation in this study, each subject will read a.l1d sign a consent form. Participants in this
study will all be capable of independent decision m.aking and will sign a consent foml stating their
understanding and willingness to patiicipate in this study. Paliicipants will be encouraged to ask atly
questions regarding the consent fon11 to ensure their uuderstanding of the document. Each participant
will be provided the opportunity to receiYe 2. copy of the consent fon'-1 for their records.
d)

Describe the protocol regarding record retention. Please indicate that research data ii-om this study and consent fonns will
both be retained in separate locked locations for a minimum of three years following the completion of the study.

Describe: 1) the storage location ofthe research data (separate from consent forms and subject personal data)
2) who will have access to the data
3) how the data will be destroyed
4) the storage location of consent forms and personal data (separate from research data)
5) how the consent forms will be destroyed

Participant consent forms and data (collection sheets and electronic files) will be stored separately and
secured in separate locked locations in the Department of Physical Therapy. Only the principal
investigator will have access to both the consent forms and data. Subject data AND CONSENT
FORMS WILL BE RETAINED INRM 1521 IN SEPARATE, LOCKED FILE CABINETS. After a
period of3 years from the completion of the study, the consent forms and data collection sheets will
be shredded. Electronic data will be deleted or destroyed from all disks/drives.
e)

Describe procedures to deal with adverse reactions (referrals to helping agencies, procedures for dealing with trauma, etc.).

The investigators or participant may stop the experiment at any time if the participant is experiencing
discomfort, pain, abnormal fatigue, or any other symptoms that may be detrimental to their health. If
subjects consent to participate they will be allowed to terminate their participation in this study at any
time without prejudice or jeopardizing any future relationships with the UND Department of Physical
Therapy. Medical treatment will be provided to each subject as needed, including first aid, CPR, and
follow-up care as that provided to a member of the general public in a similar circumstance.
f)

Include an explanation of medical treatment available if injury or adverse reaction occurs and responsibility for costs
involved.

In the event an adverse event occurs during participation in this study, the subject will be prompted to
seek immediate medical attention. All incurred medical expenses will be the responsibility of the
subject or the subject's third-party payer.
III. Benefits oUbe Study
Clearly describe the benefits to the subject and to society resulting from this study (such as learning experiences, services
received, etc.). Please note: extra credit andlor payment are not benefits and should be listed in the Protocol Description section
under Methodology.

Possible benefits of this study include but are not limited to: 1) furthering the knowledge concerning the
muscle activity used in different breath recovery positions; 2) furthering the knowledge concerning the
breath volume in different recovery positions; 3) further research may be stimulated. Subjects participating
in the study will not receive any compensation nor will they incur any cost associated with this study.
IV. Consent Form
Clearly describe the consent process below and be sure to include the following information in your description (Note: Simply
stating 'see attached consent form' is not sufficient. The items listed below must be addressed on this form.):
1) The person who will conduct the consent interview
2) The person who will provide consent or permission
3) Any waiting period between informing the prospective participant and obtaining consent
4) Steps taken to minimize the possibility of coercion or undue influence
5) The language to be used by those obtaining consent
6) The language understood by the prospective participant or the legally authorized representative
7) The information to be communicated to the prospective participant or the legally authorized representative

The person to conduct the consent interview will be Dr. David ReIling. Consent will be provided by
the subj ect. Since the study is a one time event with minimal risk, there will be no waiting time between
-------:ic"ncFfo"IM·mYITiiI""l&rtne-siIOjecrand consent. The investigator wiH-<ll.IDOUncFtne-opponunityto p31iicipate anapost--the appropriate sign while key personnel recruit subjects. Removing the PI from recruitment should
decrease undue influence from the faculty lead study. ENGLISH WILL BE USED FOR OBTAINING
CONSENT AND ALL SUBJECTS MUST BE ABLE TO U1\[DERSTAND AND UTILIZE ENGLISH.
Information communicated to the prospective participant will include a reading of the study purpose and
what will happen from the informed consent form.
A copy of the consent fonn must be attach2d to tllls proposal. Ifno consent fonn is to be used, document the procedures to be
used to protect human subjects, and complete the Application for Waiver or Alteration ofInformed Consent Requirements. Refer

to form IC 701-A, Informed Consent Checklist, and make sure that all the reqnired elements are inclnded. Please note; All
records attained must be retained for a period of time sufficient to meet federal, state, and local regulations; sponsor
reqnirements; and organizational policies. The consent form must be written in language that can easily be read by the subject
population and any nse of jargon or technicallangnage should be avoided. The consent form shon1d be written at no higher
than an 8 th grade reading level, and it is recommended that it be written in the third person (please see the example on the
RD&C website). A two inch by two inch blank space must be left on the bottom of each page ofthe consent form for the IRE
approval stamp.
Necessary attachments:

I3J Signed Student Consent to Release of Educational Record Fonn (students and medical residents only);

IZI Investigator Letter of Assurance of Compliance; (all researchers)
IZJ Consent fonn, or Waiver or Alteration of Informed Consent Requirements (Fonn Ie 702-B)

I:8J Key Personnel Listing
I3J Surveys, interview questions, etc. (if applicable);
D Printed web screens (if survey is over the Internet); and
I3J Advertisements (flyer, social media po stings, emaWletters, etc.).

By signing below, you are verifying that the information provided in the Human Subjects Review Form and attached
information is accnrate and that the project will be completed as indicated.

(Principal Investigator)

Date:

(Student Advisor)

Date:

I

f

**All students and medical residents must list a faculty member as a student advisor on the first page of the
application and must have that person sign Ihe application. **

Requirements for submitting proposals:
Additional information can be found on the IRE website at:

httn:/lund.edq/research/resources/hulYiQn-subli,;,(i~: ii1(;,'

Original, signed proposals and all attachments, along with the necessary number of copies (see below), should be submitted to:
Institutional Review Board, 264 Centennial Drive Stop 7134, Grand Forks, ND 58202-7134, or brought to Room 106, Twamley
Hall.
Required Number of Copies:
• Expedited Review: Submit the signed original and 1 copy of the entire proposal.
• Full Board Review: Submit the signed original and 22 copies of the entire proposal by the deadline listed on the IRE
website: b..ll.R: /1 un d. ed uJres earc hires a urces/h lim an -sub jects/m eet i ng-5 ch ed u1c. cfm
• Clinical Medical Subcommittee and Full Board Review: Submit the signed original and 24 copies of the entire proposal
by the deadlme listed on the IRE website: bttp://und.edu/research/resources!humm~ }ul}iectsirn
l -''-'';

Prior to receiving IRB approval, researchers lllUst complete the required IRE hrunan subjects' education. Please go to:
bJ.~J!~/.,'und edu/!"e stare b/reso urces/hum C]]l::$U b i ects/h uman-su b i eet-education. en.ll
>

----~Tfl}w-eri-te-ria-for-determ·illing-w-hat---eat-eg_e)l'y-y~ooal---wiH--be

rellic{,·"d tl11del'-is listed on-pagc 3 of the IR:B---€heck-:l-i-s-~'
reviewer will assign a review category to your proposal. Should your protocol require full Board review, you Ivill need to
provide additional copies. Further infOlmation can be found on the IRB Ivebsite regarding required copies and IRE review
categories, or you lllay call the IRB office at 701 777-4279.

In cases 'i'idlCre the proposed \vork is part of a proposal to a potential funding source, one copy of the completed proposa 1
funding agency (agrecmcnt/contnct if there is no proposal) must be 2.TIached to the completed Human Subjects Revie.,.
the proposal is non-clinical; 5 copies if the proposal is clinical-medical. If the proposed work is being conducted for
ph2nnaceutical compan:y, 5 copies oftlle company's protocol must be provided.

INVESTIGATOR LETTER OF ASSURANCE OF COMPLIANCE
WITH ALL APPLICABLE FEDERAL REGULATIONS FOR THE
PROTECTION OF THE RIGHTS OF HUMAN SUBJECTS

I David P. ReIling, PT, Ph.D.
(Name ofInvestigator)
agree that, in conducting research under the approval of the University of North Dakota
Institutional Review Board, I will fully comply and assume responsibility for the
enforcement of compliance with all applicable federal regulations and University policies
for the protection of the rights of human subjects engaged in research. Specific
regulations include the Federal Common Rule for Protection ofthe Rights of Human
Subjects 45 CFR 46. I will also assure compliance to the ethical principles set forth in
the National Commission for the Protection of Human Subjects of Biomedical and
Behavioral Research document, The Belmont Report.
I understand the University's policies conceming research involving human subjects and
agree to the following:
1. Should I wish to make changes in the approved protocol for this project, I will
submit them for review PRIOR to initiating the changes. (A proposal may be
changed without prior IRB approval where necessary to eliminate apparent
immediate hazards to the subjects or others. However, the IRB must be notified in
writing within 72 hours of any change, and IRB review is required at the next
regularly scheduled meeting of the full IRB.)
2. If any problems involving human subjects occur, I will immediately notify the
Chair of the IRB, or the IRB Coordinator.
3. I will cooperate with the UND IRB by submitting Research Project Review and
Progress Reports in a tinlely manner.
I understand the failure to do so may result in the suspension or termination of proposed
research and possible reporting to federal agencies.

--------Investigator-Sign:atti'le

10/1/06

UNIVERSITY OF NORTH DAKOTA
INSTITUTIONAL REVIEW BOARD
KEY PERSONNEl LISTING
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----

Names of l1~scilrch Persoonel :
First Name
Last Name

Position
(select from drop-down menu)

1 DilVicJ

f(elling

Faculty

Joel

I(ramer

Graduate student

~.

Meyer

Graduate student

--'
3

4 Eric

I--", Daniel _ _ _ _ _ .

r-' --_._..
e

Nefstead

Graduate student

Vilaubi

Graduate student

".-~--.-

._- -

Highest Academic Degree
(High School, 5.S, M.A., Ph.D., M.D., etc.)
Ph.D.

licenses/Certifications
(If applicable)

er

_
Consent Subjects

'"
0

" Attach proof o!ed1lcotioll in !Juma" subje ts research for all non-UND personnel

0

'"

0

'"

Data Analysis

'"

0

'"
'"
'"
'"
0

0

'"
'"
'"
'"
0

'"
'"
'"
'"

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0
0
0
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Responsibilities (check all that apply)
Research Design
Recruit Subjects
Intervention

0
0
0

0

ill #: PulmEMG15-_ __

TITLE: EMG Activity of Accessory Muscles of
Breathing during Recovery Positions

Subject Questionnaire and Data Collection
Age:- - - - - - -

Height

Gender: _ _ _ _ _ __

Weight

1) Do you have any difficulty with breathing or physical activity? YES/NO
If YES, please explain: _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
2) Have you had any injuries to your chest or back in the past 3 months? YES/NO
If YES, please explain: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
3) Have you experienced itching, rash or initation from bandages or adhesives on
tape? YES/NO
If YES, please explain:_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

POSITION
Standing Arms at Sides
Standing Hands on Head
Standing Hands on Knees
Sitting Anus Supported

MINUTE VENTILATION

EXPECTED LUNG VOLUMES (from prediction equations based on age, gender &
height) .
MEASURE
PREDICTION
ACTUAL
FVC
FEV!
IRV
ERV

INFORMED CONSENT
TITLE:

EMG Activity of Accessory Muscles of Breathing during
Recovery Positions

PROJECT DIRECTOR:

David Reiling, PT, Ph.D.

PHONE #

(701)777-4091

DEPARTMENT:

Physical Therapy

STATEMENT OF RESEARCH
A person who is to participate in the research must give his or her informed consent to such
participation. This consent must be based on an understanding of the nature and risks of the
research. This document provides information that is important for this understanding. Research
projects include only subjects who choose to take part. Please take your time in making your
decision as to whether to participate. If you have questions at any time, please ask.
WHAT IS THE PURPOSE OF TIDS STUDY?
You are invited to take part in a research study conducted by David Relling, a faculty member of
the Department of Physical Therapy at the University of North Dakota. The purpose of this
study is to better understand the effect of recovery body positions on breathing volume and
activity of accessory muscles of breathing. Example recovery positions include hands on your
knees or hands on your head. Accessory muscles of breathing include larger muscles of the
chest, neck and back. You were selected because you are over the age of 18, do not have any
lung diseases, difficulty breathing or recent injuries.
HOW MANY PEOPLE WILL P ARTICIPATE?
Approximately 30 people will take part in this study at the University of North Dakota.
HOW LONG WILL I BE IN TIDS STUDY?
Your participation in the study will last for 1 session of approximately 1 hour. You will need to
visit the physical therapy department (501 N Columbia Rd, Room 1510, and its research lab,
Room 2541) where the study will take place.
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WHAT WILL HAPPEN DURING TmS STUDY?
You will complete a form that asks about your age, height, weight, gender, breathing problems
or injuries. The information is needed to predict the "normal" or expected air capacity of your
lungs and eligibility to participate in the study. Following completion of the form, the
researchers will prepare to collect information regarding your muscles' activity using
electromyography (EMG). EMG uses small, adhesive-backed electrodes attached to the skin and
a device that can detect the electrical activity present in muscles at rest and in action. The
device does not give off an electrical current or shock to your body-it only detects electrical
activity present in muscles over which electrodes are attached. The researchers will clip any hair
present over areas of muscle on which electrodes are to be placed. This will be followed by
rubbing the skin lightly with sandpaper and an alcohol wipe in order to improve the ability to
detect electrical activity. The electrodes will convey electrical information to the device for
actual measurement. Once electrodes are in place, computer information will be recorded as you
breath strongly through a mouthpiece connected to a spirometer for fifteen seconds. The
spirometer measures the amount of air you inhale and exhale. You will perform the spirometer
activity in four different recovery positions: standing with arms relaxed, standing with hands on
your head, standing with hands on your knees and sitting with forearms on a table.
WHAT ARE THE RISKS OF THE STUDY?
There may be some risk from being in this study, such as the small risk of mild skin irritation at
the site ofthe electrode that reads the muscle activity, a conunon short-lasting occurrence in
studies using EMG. Steps will be taken to ensure your modesty and comfort by covering areas
where electrode application may approach more personal body areas, such as the chest, back and
neck.
If you are pregnant or become pregnant during the study, we foresee no additional risks to you or
the baby during the course of the research.
WHAT ARE THE BENEFITS OF TmS STUDY?
You may not benefit personally from being in this study. However, we hope that, in the future,
other people might benefit from this study because results from this research may help the
understanding of optimal positions and accessory muscles for overcoming difficulty with
breathing.
WILL IT COST ME ANYTmNG TO BE IN TmS STUDY? WILL I BE PAID?
You will not have any costs for being in this research study other than perhaps traveling or
parking costs. You will not be paid for being in this research study.
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The University of North Dako"w_ and the research team are reC<oiving no payments from other
agencies, organizations, or c01J1panies to conduct tins research sttLdy.
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CONFIDENTIALITY
The records of this study will be kept private to the extent permitted by law. In any report about
this study that might be published, you will not be identified. Your study record may be reviewed
by Government agencies, the UND Research Development and Compliance office, and the
University of North Dakota Institutional Review Board.
Any information that is obtained in this study and that can be identified with you will remain
confidential and will be disclosed only with your permission or as required by law.
Confidentiality will be maintained by means of coding data and computer files with an
independent number for each subject. You should know, however, that there are some
circumstances in which we may have to show your information to other people. For example the
law may require us to show your information to a court or to tell authorities if we believe you
have abused a child, or you pose a danger to yourself or someone else. Confidentiality will be
maintained by means of storing of all records and research information in separate locked file
cabinets in Room 1521 of the Physical Therapy Department. All collected research information
and records will be destroyed by shredding after 3 years.
If we write a report or article about this study, we will describe the study results in a summarized
manner so that you cannot be identified.
COMPENSATION FOR INJURY
In the event that this research activity results in an injury, treatment will be available including
first aid, emergency treatment and follow-up care as needed. Payment for any such treatment is
to be provided by you (you will be billed) or your third-party payer, if any (such as health
insurance, Medicare, etc.) No funds have been set aside to compensate you in the event of injury.
Also, the study staff cannot be responsible if you knowingly and willingly disregard the
directions they give you.
IS THIS STUDY VOLUNTARY?
Your participation is voluntary. You may choose not to participate or you may discontinue your
participation at any time without penalty or loss of benefits to which you are otherwise entitled.
Your decision whether or not to participate will not affect your current or future relations with
the University of North Dakota.
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CONTACTS AND QUESTIONS
The researcher conducting this study is David ReIling. You may ask any questions you have now
or anytime during your participation in the study. If you later have questions, concerns, or
complaints about the research please contact David Reiling in the Physical Therapy Department
at 777-2831 during the day and at (701)741-3481 after hours. If you have questions regarding
your rights as a research subject, or if you have any concerns or complaints about the research,
you may contact the University of North Dakota Institutional Review Board at (701) 777-4279.
• You may also call this number about any problems, complaints, or concerns you have
about this research study.
• You may also call this number if you canllot reach research staff, or you wish to talk with
someone who is independent ofthe research team.
• General information about being a research subject can be found by clicking
"Information for Research Participants" on the web site:
http://und.edu/researchiresources/human-subj ectslresearch-parti ci Dan'~sEL,'

Your signature indicates that this research study has been explained to you, that your questions
have been answered, and that you agree to take part in this study_ You will receive a copy of this
form.

Su~ectsName:

__________________________________~~~~________

Date

Signature of Subj eet

I have discussed the above points with the subject or, where appropriate, with the subject's
legally authorized representative.

Signature of Person Who Obtained Consent

lJ:::t:=',
Subject Initials: ____

Date

:;. of ~!.

This document identifies the EMG electrode placements for the study titled EMG Activity of Accessory
Muscles of Breathing during Recovery Positions .
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